DANBURY, Conn., Oct. 28, 2015 /PRNewswire-USNewswire/ -- The National Organization for Rare Disorders (NORD) has published a Physician Guide to Nontuberculous Mycobacterial Lung Disease to promote awareness of this rare disorder among physicians and other medical professionals.
"We are pleased to announce this newest addition to our Physician Guide series," said NORD President and CEO Peter L. Saltonstall. "This series is part of NORD's outreach to medical professionals to reduce the time to diagnosis and promote optimal treatment for patients with rare diseases."
The new Physician Guide was written by Leah Lande, M.D., of the Division of Pulmonary and Critical Care Medicine, Lankenau Medical Center. Dr. Lande is also a member of the faculty of Jefferson University Medical College.
Nontuberculous mycobacteria (NTM) are naturally occurring organisms found in water and soil that, when inhaled, may cause lung infection in some susceptible individuals. More than 140 species of these mycobacteria have been identified to date.
In most cases, these organisms do not cause infection. However, in some individuals, for reasons that are not fully understood, exposure to NTM in the environment can lead to infection that, in severe cases, may result in chronic lung disease requiring ongoing treatment.
NORD is publishing this guide in partnership with its member organization, NTM Info & Research Inc., which provides support and information to patients and families affected by NTM lung disease. The NTM Info & Research website is at http://www.ntminfo.org/.
As the primary nonprofit organization representing Americans with rare diseases, NORD established its NORD Physician Guides as part of a broader strategic initiative to promote earlier diagnosis and state-of-the-art care for people with rare diseases. Each online guide is written by a medical professional with expertise on the topic. The guides cover signs & symptoms, diagnosis, treatment, investigational therapies, and other related topics.
Other recent guides in the series include The Physician Guide to Lipoprotein Lipase Deficiency, The Physician Guide to Homozygous Familial Hypercholesterolemia and The Physician Guide to Infantile Spasms.
The NTM guide was made possible by an educational grant from Insmed Inc. NORD and the author are solely responsible for the content.
About the National Organization for Rare Disorders (NORD)®
Established in 1983, the National Organization for Rare Disorders (NORD)® is the largest rare disease organization in the U.S. and the leading independent nonprofit representing all patients and families affected by rare diseases. NORD is committed to the identification, treatment and cure of all 7,000 rare diseases that affect 30 million Americans, or 1 in every 10 people. NORD provides programs of advocacy, education, research, and patient and family services to improve the lives of all people living with rare diseases. NORD represents more than 230 disease-specific member organizations and collaborates with many other organizations in specific causes of importance to the rare disease patient community. Join NORD at www.rarediseases.org/ and on Twitter at @RareDiseases.
SOURCE National Organization for Rare Disorders (NORD)